12.04 USD
+0.02
0.17%
At close Dec 20, 4:00 PM EST
After hours
12.04
+0.00
0.00%
1 day
0.17%
5 days
-0.33%
1 month
-19.19%
3 months
-31.04%
6 months
-27.03%
Year to date
-40.84%
1 year
-39.77%
5 years
-65.10%
10 years
-34.67%
 

About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Employees: 1,315

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

288% more call options, than puts

Call options by funds: $3.37M | Put options by funds: $868K

9% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 116

0% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]

2% less capital invested

Capital invested by funds: $4.02B [Q2] → $3.95B (-$66.6M) [Q3]

3% less funds holding

Funds holding: 345 [Q2] → 333 (-12) [Q3]

10.1% less ownership

Funds ownership: 118.66% [Q2] → 108.56% (-10.1%) [Q3]

31% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 39

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$15
25%
upside
Avg. target
$15
25%
upside
High target
$15
25%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Guggenheim
Subbu Nambi
50% 1-year accuracy
4 / 8 met price target
25%upside
$15
Buy
Initiated
19 Dec 2024

Financial journalist opinion

Based on 4 articles about NEOG published over the past 30 days

Neutral
PRNewsWire
1 day ago
Neogen® Announces Second-Quarter Earnings Release Date
LANSING, Mich. , Dec. 19, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on Thursday, January 9, 2025.
Neogen® Announces Second-Quarter Earnings Release Date
Positive
Zacks Investment Research
2 days ago
NEOG Stock Gains From New Addition to the Petrifilm Product Line
Neogen expands the Petrifilm product line with the introduction of Petrifilm Bacillus cereus Count Plate.
NEOG Stock Gains From New Addition to the Petrifilm Product Line
Neutral
PRNewsWire
3 days ago
Neogen® Launches Petrifilm® Bacillus cereus Count Plate to Enhance Food Safety Testing Efficiency
LANSING, Mich. , Dec. 17, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, has introduced a new addition to its Petrifilm® product line, the Neogen Petrifilm Bacillus cereus Count Plate.
Neogen® Launches Petrifilm® Bacillus cereus Count Plate to Enhance Food Safety Testing Efficiency
Neutral
PRNewsWire
3 weeks ago
Neogen® to Participate in the 36th Annual Piper Sandler Healthcare Conference
LANSING, Mich. , Nov. 27, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 36th Annual Piper Sandler Healthcare Conference in New York City on Wednesday, December 4, 2024.
Neogen® to Participate in the 36th Annual Piper Sandler Healthcare Conference
Negative
Zacks Investment Research
1 month ago
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
NEOG faces intense competition resulting from competitors' development of new technologies, which could affect the marketability and profitability of its products.
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
Neutral
PRNewsWire
1 month ago
Neogen® To Participate in 2024 UBS Global Healthcare Conference
LANSING, Mich. , Nov. 5, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12.
Neogen® To Participate in 2024 UBS Global Healthcare Conference
Negative
Zacks Investment Research
2 months ago
Neogen Q1 Earnings Miss Estimates, Margins Crash
NEOG's Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the first quarter of fiscal 2025.
Neogen Q1 Earnings Miss Estimates, Margins Crash
Negative
Seeking Alpha
2 months ago
Neogen Stock: Expect Volatility To Continue Amid Weak Growth
Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound.
Neogen Stock: Expect Volatility To Continue Amid Weak Growth
Positive
Zacks Investment Research
2 months ago
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Neutral
Seeking Alpha
2 months ago
Neogen Corporation (NEOG) Q1 2025 Earnings Call Transcript
Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.
Neogen Corporation (NEOG) Q1 2025 Earnings Call Transcript
Charts implemented using Lightweight Charts™